Top

Acta Neurochirurgica

Published in:

01-12-2010 | Letter to the Editor

DBS: Should the STN be avoided in progressive Parkinson’s disease?

Author: Christian Saleh

Published in: Acta Neurochirurgica | Issue 12/2010

Excerpt

Dear Sir, …

Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P (1999) Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46:217–223CrossRefPubMed

Benabid AL, Chabardes S, Seigneuret E (2005) Deep-brain stimulation in Parkinson’s disease: long-term efficacy and safety—What happened this year? Curr Opin Neurol 18:623–630CrossRefPubMed

Berney A, Vingerhoets F, Perrin A, Guex P, Villemure JG, Burkhard PR, Benkelfat C, Ghika J (2002) Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology 59:1427–1429PubMed

Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J (2004) Suicide after successful deep brain stimulation for movement disorders. Neurology 63:2170–2172PubMed

Burn DJ, Troster AI (2004) Neuropsychiatric complications of medical and surgical therapies for Parkinson’s disease. J Geriatr Psychiatry Neurol 17:172–180CrossRefPubMed

Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A (2007) Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:248–252CrossRefPubMed

Cyron D, Funk M, Deletter MA, Scheufler K (2010) Preserved cognition after deep brain stimulation (DBS) in the subthalamic area for Parkinson's disease: a case report. Acta Neurochir (Wien) (in press)

Foncke EM, Schuurman PR, Speelman JD (2006) Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 66:142–143CrossRefPubMed

Houeto JL, Mallet L, Mesnage V, Tezenas du Montcel S, Behar C, Gargiulo M, Torny F, Pelissolo A, Welter ML, Agid Y (2006) Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Arch Neurol 63:1090–1095CrossRefPubMed

10.

Kaiser I, Kryspin-Exner I, Brucke T, Volc D, Alesch F (2008) Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up. BMC Neurol 8:43CrossRefPubMed

11.

Kalteis K, Standhardt H, Kryspin-Exner I, Brucke T, Volc D, Alesch F (2006) Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm 113:1191–1206CrossRefPubMed

12.

Kostic VS, Pekmezovic T, Tomic A, Jecmenica-Lukic M, Stojkovic T, Spica V, Svetel M, Stefanova E, Petrovic I, Dzoljic E (2010) Suicide and suicidal ideation in Parkinson's disease. J Neurol Sci 289:40–43CrossRefPubMed

13.

Kummer A, Cardoso F, Teixeira AL (2009) Suicidal ideation in Parkinson's disease. CNS Spectr 14:431–436PubMed

14.

Oguru M, Tachibana H, Toda K, Okuda B, Oka N (2010) Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 23:35–41CrossRefPubMed

15.

Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI (2006) Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 5:578–588CrossRefPubMed

16.

Rodrigues AM, Rosas MJ, Gago MF, Sousa C, Fonseca R, Linhares P, Basto MA, Sousa G, Garrett C, Vaz R (2010) Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease. Eur Neurol 63:176–179CrossRefPubMed

17.

Saleh C (2010) STN DBS and suicide: is tangential evidence, evidence enough? Eur Neurol 63:372–373, author reply 373CrossRefPubMed

18.

Saleh C (2010) The need for more evidence-based reporting in deep brain stimulation. Neurol India 58:503CrossRefPubMed

19.

Saleh C, Okun MS (2008) Clinical review of deep brain stimulation and its effects on limbic basal ganglia circuitry. Front Biosci 13:5708–5731CrossRefPubMed

20.

Schupbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltete D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y (2005) Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 76:1640–1644CrossRefPubMed

21.

York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J (2008) Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 79:789–795CrossRefPubMed

22.

Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, Bowers D (2009) Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change. Clin Neuropsychol 23:385–405CrossRefPubMed

Title: DBS: Should the STN be avoided in progressive Parkinson’s disease?
Author: Christian Saleh
Publication date: 01-12-2010
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 12/2010
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-010-0814-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

DBS: Should the STN be avoided in progressive Parkinson’s disease?

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2010

Can systematic analysis of morbidity and mortality reduce complication rates in neurosurgery?

A 10-year follow-up of extracranial–intracranial bypass for the treatment of bilateral giant internal carotid artery aneurysms in a patient with fibromuscular dysplasia: case report

Role of degenerated neuron density of dorsal root ganglion on anterior spinal artery vasospasm in subarachnoid hemorrhage: experimental study

Substantia nigra hyperechogenicity in Parkinson’s disease

Surgical treatment of trigeminal neuralgia. Results from the use of glycerol injection, microvascular decompression, and rhizotomia

Hyponatremia is predictable in patients with aneurysmal subarachnoid hemorrhage—clinical significance of serum atrial natriuretic peptide